COR vs. CAH

Last updated Apr 2, 2026

Compare and contrast key facts about Cencora Inc. (COR) and Cardinal Health, Inc. (CAH).

Performance

COR vs. CAH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cencora Inc. (COR) and Cardinal Health, Inc. (CAH). The values are adjusted to include any dividend payments, if applicable.

COR vs. CAH - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
COR Cencora Inc.	-5.79%	51.48%	10.37%	25.33%	26.26%	44.09%	23.37%	23.51%	-17.57%	19.51%
CAH Cardinal Health, Inc.	3.68%	76.25%	19.01%	34.15%	54.08%	-0.40%	10.09%	18.04%	-24.50%	-12.65%

Fundamentals

Market Cap COR : $62.05B CAH : $50.25B
EPS COR : $8.34 CAH : $6.98
PE Ratio COR : 38.08 CAH : 30.37
PEG Ratio COR : 18.09 CAH : 0.72
PS Ratio COR : 0.19 CAH : 0.21
Total Revenue (TTM) COR : $325.78B CAH : $244.49B
Gross Profit (TTM) COR : $10.95B CAH : $8.86B
EBITDA (TTM) COR : $3.54B CAH : $3.23B

Returns By Period

In the year-to-date period, COR achieves a -5.79% return, which is significantly lower than CAH's 3.68% return. Over the past 10 years, COR has outperformed CAH with an annualized return of 17.31%, while CAH has yielded a comparatively lower 13.09% annualized return.

COR

• 1D: 1.12%
• 1M: -14.76%
• YTD: -5.79%
• 6M: 2.23%
• 1Y: 15.33%
• 3Y*: 26.76%
• 5Y*: 24.24%
• 10Y*: 17.31%

CAH

• 1D: 0.58%
• 1M: -7.55%
• YTD: 3.68%
• 6M: 34.91%
• 1Y: 56.36%
• 3Y*: 43.43%
• 5Y*: 31.34%
• 10Y*: 13.09%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

COR vs. CAH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

COR

COR Risk / Return Rank: 59
COR Sharpe Ratio Rank: 62
COR Sortino Ratio Rank: 53
COR Omega Ratio Rank: 54
COR Calmar Ratio Rank: 60
COR Martin Ratio Rank: 65

CAH

CAH Risk / Return Rank: 90
CAH Sharpe Ratio Rank: 89
CAH Sortino Ratio Rank: 90
CAH Omega Ratio Rank: 90
CAH Calmar Ratio Rank: 92
CAH Martin Ratio Rank: 89

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

COR vs. CAH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cencora Inc. (COR) and Cardinal Health, Inc. (CAH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	COR	CAH	Difference
Sharpe ratio Return per unit of total volatility	0.60	1.89	-1.28
Sortino ratio Return per unit of downside risk	0.94	2.86	-1.92
Omega ratio Gain probability vs. loss probability	1.13	1.40	-0.27
Calmar ratio Return relative to maximum drawdown	0.88	4.36	-3.49
Martin ratio Return relative to average drawdown	2.72	9.99	-7.27
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

COR vs. CAH - Sharpe Ratio Comparison

The current COR Sharpe Ratio is 0.60, which is lower than the CAH Sharpe Ratio of 1.89. The chart below compares the historical Sharpe Ratios of COR and CAH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	COR	CAH	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.60	1.89	-1.28
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	1.16	1.25	-0.09
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.64	0.45	+0.19
Sharpe Ratio (All Time) Calculated using the full available price history	0.57	0.57	0.00

Correlation

The correlation between COR and CAH is 0.53, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

COR vs. CAH - Dividend Comparison

COR's dividend yield for the trailing twelve months is around 0.72%, less than CAH's 0.96% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
COR Cencora Inc.	0.72%	0.67%	0.93%	0.96%	1.13%	5.13%	6.74%	7.48%	2.07%	1.61%	1.77%	1.17%
CAH Cardinal Health, Inc.	0.96%	0.99%	1.28%	1.98%	2.57%	3.80%	3.62%	3.80%	4.24%	3.00%	2.41%	1.68%

Drawdowns

COR vs. CAH - Drawdown Comparison

The maximum COR drawdown since its inception was -71.01%, which is greater than CAH's maximum drawdown of -61.93%. Use the drawdown chart below to compare losses from any high point for COR and CAH.

Drawdown Indicators

	COR	CAH	Difference
Max Drawdown Largest peak-to-trough decline	-71.01%	-61.93%	-9.08%
Max Drawdown (1Y) Largest decline over 1 year	-17.16%	-12.88%	-4.28%
Max Drawdown (5Y) Largest decline over 5 years	-17.84%	-24.69%	+6.85%
Max Drawdown (10Y) Largest decline over 10 years	-31.76%	-47.23%	+15.47%
Current Drawdown Current decline from peak	-15.09%	-7.55%	-7.54%
Average Drawdown Average peak-to-trough decline	-13.57%	-15.96%	+2.39%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.53%	5.63%	-0.10%

Volatility

COR vs. CAH - Volatility Comparison

Cencora Inc. (COR) has a higher volatility of 7.34% compared to Cardinal Health, Inc. (CAH) at 6.99%. This indicates that COR's price experiences larger fluctuations and is considered to be riskier than CAH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	COR	CAH	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.34%	6.99%	+0.35%
Volatility (6M) Calculated over the trailing 6-month period	18.78%	22.81%	-4.03%
Volatility (1Y) Calculated over the trailing 1-year period	25.61%	30.04%	-4.43%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	20.98%	25.21%	-4.23%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.00%	29.25%	-2.25%

Financials

COR vs. CAH - Profitability Comparison

The chart below illustrates the profitability comparison between Cencora Inc. and Cardinal Health, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

COR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Cencora Inc. reported a gross profit of 3.07B and revenue of 85.93B. Therefore, the gross margin over that period was 3.6%.

CAH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Cardinal Health, Inc. reported a gross profit of 2.21B and revenue of 65.44B. Therefore, the gross margin over that period was 3.4%.

COR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Cencora Inc. reported an operating income of 760.45M and revenue of 85.93B, resulting in an operating margin of 0.9%.

CAH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Cardinal Health, Inc. reported an operating income of 707.00M and revenue of 65.44B, resulting in an operating margin of 1.1%.

COR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Cencora Inc. reported a net income of 559.65M and revenue of 85.93B, resulting in a net margin of 0.7%.

CAH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Cardinal Health, Inc. reported a net income of 471.00M and revenue of 65.44B, resulting in a net margin of 0.7%.